MD2, Cystatin C and DNA Methylation Tags as Serum Biomarkers for POCD.

Clinical trial NCT03610191 · UNKNOWN

Trial details

NCT number: NCT03610191
Sponsor: Xijing Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Postoperative Cognitive Dysfunction

Start date: 2018-11-20
Primary completion: 2021-09-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.